Annual Total Assets
$130.39 M
+$79.75 M+157.50%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual total assets is $130.39 million, with the most recent change of +$79.75 million (+157.50%) on December 31, 2023.
- During the last 3 years, CTNM annual total assets has risen by +$59.87 million (+84.90%).
- CTNM annual total assets is now at all-time high.
Performance
CTNM Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$216.03 M
-$5.32 M-2.40%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly total assets is $216.03 million, with the most recent change of -$5.32 million (-2.40%) on September 30, 2024.
- Over the past year, CTNM quarterly total assets has increased by +$85.65 million (+65.69%).
- CTNM quarterly total assets is now -2.40% below its all-time high of $221.35 million, reached on June 30, 2024.
Performance
CTNM Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
CTNM Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +157.5% | +65.7% |
| 3 y3 years | +84.9% | +326.6% |
| 5 y5 years | +84.9% | +326.6% |
CTNM Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +157.5% | -2.4% | +326.6% |
| 5 y | 5-year | at high | +157.5% | -2.4% | +326.6% |
| alltime | all time | at high | +157.5% | -2.4% | +326.6% |
Contineum Therapeutics Class A Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $216.03 M(-2.4%) |
| Jun 2024 | - | $221.35 M(+79.1%) |
| Mar 2024 | - | $123.56 M(-5.2%) |
| Dec 2023 | $130.39 M | $130.39 M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $139.04 M(+174.6%) |
| Dec 2022 | $50.64 M(-28.2%) | - |
| Dec 2022 | - | $50.64 M |
| Dec 2021 | $70.52 M | - |
FAQ
- What is Contineum Therapeutics Class A annual total assets?
- What is the all time high annual total assets for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual total assets year-on-year change?
- What is Contineum Therapeutics Class A quarterly total assets?
- What is the all time high quarterly total assets for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly total assets year-on-year change?
What is Contineum Therapeutics Class A annual total assets?
The current annual total assets of CTNM is $130.39 M
What is the all time high annual total assets for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual total assets is $130.39 M
What is Contineum Therapeutics Class A annual total assets year-on-year change?
Over the past year, CTNM annual total assets has changed by +$79.75 M (+157.50%)
What is Contineum Therapeutics Class A quarterly total assets?
The current quarterly total assets of CTNM is $216.03 M
What is the all time high quarterly total assets for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly total assets is $221.35 M
What is Contineum Therapeutics Class A quarterly total assets year-on-year change?
Over the past year, CTNM quarterly total assets has changed by +$85.65 M (+65.69%)